Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.


  1. Advanced Patent Search
Publication numberUSD434153 S
Publication typeGrant
Application numberUS 29/086,781
Publication date21 Nov 2000
Filing date20 Apr 1998
Publication number086781, 29086781, US D434153 S, US D434153S, US-S-D434153, USD434153 S, USD434153S
InventorsEmory V. Anderson, Ricardo Martinez
Original AssigneeAdeza Biomedical Corporation
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Point of care analyte detector system
US D434153 S
Abstract  available in
Previous page
Next page
  1. The ornamental design for a point of care analyte detector system, as shown and described.

FIG. 1 is a perspective view of a point of care analyte detector system, showing our new design;

FIG. 2 is a top plan view thereof;

FIG. 3 is a left side elevational view thereof;

FIG. 4 is a right side elevational view thereof;

FIG. 5 is a front view thereof; and,

FIG. 6 is a rear view thereof.

Non-Patent Citations
1"Artificial Intelligence Systems in Routine Clinical Use", (available on on Nov. 21, 1996).
2"BarCode 1; Code 128 Specification Page", (available on on Apr. 14, 1998).
3"Code 39 Symbology", (available on . . . /3d40bf6c892a1f6a8625645100586c88 on Apr. 14, 1998).
4"Neural Informatics Pearls of Widsom", (available on . . . hysiology/Neuro-- Pearls.html#ANN-app on Nov. 21, 1996).
5Alvager, T., et al., "The Use of Artificial Neural Networks in Biomedical Technologies: An Introduction", Biomed. Instr. Tech., 315-322 (1994).
6Baxt, W.G. and White, H., "Bootstrapping Confidence Intervals for Clinical Input Variable Effects in a Network Trained to Identify the Presence of Acute Myocardial Infarction", Neur. Comp., 7:624-638 (1995).
7Baxt, W.G., "A Neural Network Trained to Identify the Presence of Myocaridal Infarction Bases Some Decisions on Clinical Associations that Differ from Accepted Clinical Teaching", Med. Decis. Making, 14:217-222 (1994).
8Baxt, W.G., "Analysis of the Clinical Variables Driving Decision in an Artificial Neural Network Trained to Identify the Presence of Myocardial Infarction", Ann. Emerg. Med., 21(12):1439-1444 (1992).
9Baxt, W.G., "Application of Artificial Neural Networks to Clinical Medicine", The Lancet, 346:1135-1138 (1995).
10Baxt, W.G., "Complexity, Chaos and Human Physiology: The Justification for Non-linear Neural Computational Analysis", Cancer Lett., 77:85-93 (1994).
11Baxt, W.G., "Improving the Accuracy of an Artificial Neural Network Using Multiple Differently Trained Networks", Neur. Comp., 4:772-780 (1992).
12Baxt, W.G., "Use of an Articifial Neural Network for Data Analysis in Clinical Decision-Making: The Diagnosis of Acute Coronary Occlusion", Neur. Comp., 2:480-489 (1990).
13Baxt, W.G., "Use of an Artificial Neural Network for the Diagnosis of Myocardial Infarction", Ann. Int. Med., 115:843-848 (1991).
14Beksac, M.S. et al., "An Artificial Intelligent Diagnostic System with Neural Networks to Determine Genetical Disorders and Fetal Health by Using Maternal Serum Markers", Eur. Jour. Ob. Gyn. Reprod. Bio., 59:131-136 (1995).
15Benediktsson, J.A. et al., "Parallel Consensual Neural Networks with Optimally Weighted Output", Proc. World Cong. Neur. Networks, 3:129-137 (1994).
16BioComp Systems, Inc., "Systems that Learn, Adapt and Evolve", (available on on Nov. 21, 1996).
17Blinowska, A. et al., "Diagnostica--A Bayesian Decision-Aid System--Applied to Hypertension Diagnosis", IEEE Transact. Biomed. Eng., 40(3):230-235 (1993).
18Brickley, M.R. and Shepherd, J.P., "Performance of a Neural Network Trained to Make Third-molar Treatment-planning Decisions", Med. Decis. Making, 16:153-160 (1996).
19Creasy, R.K. and Resnik, R., "Maternal-Fetal Medicine: Principles and Practice", Ch.36, Sect.18, p. 657, Harcourt, Brace, Jovanovich, Inc., 1989.
20Davis, R. et al., "Production Rules as a Representation for a Knowledge-Based Consultation Program", Artif. Intel., 8:15-45 (1977).
21Diller, W., "Horus' Computer-Enhanced Diagnostics", IN VIVO: Business and Medicine Report, pp. 3-10 (1997).
22Fahlman, S.E. and Lebiere, C., "The Cascade-Correlation Learning Architecture", Adv. Neur. Informat. Proc. Syst., 2:524-532 (1989).
23Fahlman, S.E., "Faster-Learning Variations on Back-Propagation: An Empirical Study", Proc. 1988 Connectionist Models Summer School, Pittsburgh, pp. 38-51 (1988).
24Geoghegan, W.D. and Ackerman, G.A., "Adsorption of Horseradish Peroxidase, Ovomucoid and Anti-Immunoglobulin to Colloidal Gold for the Indirect Detection of Concanavalin A, Wheat Germ Agglutinin and Goat Anti-Human Immunoglobulin G on Cell Surfaces at the Electron Microscopic Level: A New Method, Theory and Application", Jour. Hist. Cytochem., 25(11):1187-1200 (1977).
25Kahn, C.E. et al., "Mammonet: Mammography Decision Support System", (available at on Nov. 21, 1996).
26Keller, P.E., "Artificial Neural Networks in Medicine", Handout / Technology brief, Pacific Northwest Laboratory.
27Kin, J. et al., "Ensemble Competitive Learning Neural Networks with Reduced Input Dimension", Int. J. Neur. Syst., 6(2):133-142 (1995).
28Kol, S. et al., "Interpretation of Nonstress Tests by an Artificial Neural Network", Am. J. Obstet. Gynecol., 172(5):1372-1379 (1995).
29LaPuerta, P. et al., "Use of Neural Networks in Predicting the Risk of Coronary Artery Disease", Comp. Biomed. Res., 28:38-52 (1995).
30Maclin, P.S. et al., "Using Neural Networks to Diagnose Cancer", J. Med. Syst., 15(1):11-19 (1991).
31Matsuura, H. and Hakomori, S., "The Oncofetal Domain of Fibronectin Defined by Monoclonal Antibody FDC-6: Its Presence in Fibronectins from Fetal and Tumor Tissues and Its Absence in Those from Normal Adult Tissues and Plasma", Proc. Natl. Acad. Sci. USA, 82:6517-6521 (1985).
32Mobley, B.A. et al., "Artificial Neural Network Predictions of Lengths of Stay on a Post-Coronary Care Unit", Heart Lung, 24(3):251-256 (1995).
33Modai, I. et al., "Clinical Decisions for Psychiatric Inpatients and their Evaluation by a Trained Neural Network", Meth. Inform. Med., 32(5):396-399 (1993).
34Moneta, C. et al., "Automated Diagnosis and Disease Characterization using Neural Network Analysis", IEEE Intl. Conf. Systs., Man, Cybernetics, USA, 1:123-128 (1992).
35Nejad, A.F. and Gedeon, T.D., "Significance Measures and Data Dependency in Classification Methods", IEEE Intl. Conf. Neur. Network Proceedings, Australia, 4:1816-1822 (1995).
36Ota, H. and Maki, M., "Evaluation of Autoantibody and CA125 in the Diagnosis of Endometriosis or Adenomyosis", Med. Sci. Res., 18:309-310 (1990).
37Pattichis, C.S. et al., "Neural Network Models in EMG Diagnosis", IEEE Trans. Biomed. Engin., 42:486-495 (1995).
38Penny, W. and Frost, D., "Neural Networks in Clinical Medicine", Med. Decis. Making, 16:386-398 (1996).
39Pollak, V. and Boulton, A.A., "An Experimental High-Performance Photodensitometer for Quantitative Chromatography", J. Chromat., 115:335-347 (1975).
40Press, W.H. et al., eds., "Numerical Recipes in C", Cambridge University Press, Second Edition, 1992.
41Rogers, S.K. et al., "Artificial Neural Networks for Early Detection and Diagnosis of Cancer", 77:79-83 (1994).
42Siganos, D., "Neural Networks in Medicine", (available at˜nd/surprise-- 96/journal/vol2/ds12/article2.html on Nov. 21, 1996).
43Snow, P.B. et al., "Artificial Neural Networks in the Diagnosis and Prognosis of Prostate Cancer: A Pilot Study", J. Urol., 152:1923-26 (1994).
44Solms, F. et al., "A Neural Network Diagnostic Tool for the Chronic Fatigue Syndrome", International Conference on Neural Networks, Paper No. 108 (1996).
45Stamey, T.A., "ProstAsure™: An Information Resource", (available at on Nov. 21, 1996).
46Stephenson, J. "RAMP: A Quantitative Immunoassay Platform Takes Shape", IVD Tech., pp. 51-56 (1996).
47Turner, D.D. and Garrett, B.A., "Coronary Artery Disease Diagnosis", Technology handout, (available on on Nov. 21, 1996).
48Utans, J. and Moody, J., "Selecting Neural Network Architectures via the Prediction Risk: Application to Corporate Bond Rating Prediction", Proceedings of the First International Conference on Artificial Intelligence Applications on Wall Street, Washington, D.C., IEEE Computer Society Press, pp. 35-41 (1991).
49Utans, J. et al., "Input Variable Selection for Neural Networks: Application to Predicting the U.S. Business Cycle", IEEE, pp. 118-122 (1995).
50Weinstein, J.N. et al., "Neural Networks in the Biomedical Sciences: A Survey of 386 Publications Since the Beginning of 1991", pp. 121-126.
51Widman, L.E., "Expert Systems in Medicine", (available on http://amplatz/ on Nov. 21, 1996).
52Wilding, P. et al., "Application of Backpropagation Neural Networks to Diagnosis of Breast and Ovarian Cancer", Cancer Lett., 77:145-153 (1994).
53Young, G.P., "Diagnosis of Acute Cardiac Ischemia", (available on http://www.library.ucs . . . 1/Originals/young.html on Nov. 21, 1996).
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US72282954 Jun 20025 Jun 2007Adeza Biomedical CorporationMethods for selecting, developing and improving diagnostic tests for pregnancy-related conditions
US7822245 *13 Feb 200726 Oct 2010Kuo-Jeng WangMethod for detecting a response of each probe zone on a test strip
U.S. ClassificationD24/216, D24/232